A Binding Potency Assay for Pritumumab and Ecto-Domain Vimentin.

[1]  M. Crúz,et al.  Recombinant Human Vimentin Binds to P-Selectin and Blocks Neutrophil Capture and Rolling on Platelets and Endothelium , 2018, The Journal of Immunology.

[2]  Shulin Li,et al.  Cell-surface vimentin–positive macrophage-like circulating tumor cells as a novel biomarker of metastatic gastrointestinal stromal tumors , 2017, Oncoimmunology.

[3]  S. Kesari,et al.  Pritumumab, the first therapeutic antibody for glioma patients. , 2017, Human antibodies.

[4]  A. Satelli,et al.  Potential Function of Exogenous Vimentin on the Activation of Wnt Signaling Pathway in Cancer Cells , 2016, Journal of Cancer.

[5]  P. Symonds,et al.  Citrullinated Vimentin Presented on MHC-II in Tumor Cells Is a Target for CD4+ T-Cell-Mediated Antitumor Immunity. , 2016, Cancer research.

[6]  Daniel F Lusche,et al.  Mediated coalescence: a possible mechanism for tumor cellular heterogeneity. , 2015, American journal of cancer research.

[7]  A. Satelli,et al.  Cell‐surface Vimentin: A mislocalized protein for isolating csVimentin+CD133− novel stem‐like hepatocellular carcinoma cells expressing EMT markers , 2015, International journal of cancer.

[8]  M. Glassy,et al.  Abstract 2658: GPEx® system to increase production of pritumumab in a CHO cell line , 2014 .

[9]  K. Vijayan,et al.  Platelet adhesion involves a novel interaction between vimentin and von Willebrand factor under high shear stress. , 2014, Blood.

[10]  S. Tsuboi,et al.  Vimentin intermediate filament and plectin provide a scaffold for invadopodia, facilitating cancer cell invasion and extravasation for metastasis. , 2014, European journal of cell biology.

[11]  K. Hochedlinger,et al.  Chromatin dynamics during cellular reprogramming , 2013, Nature.

[12]  M. Febbraio,et al.  Vimentin is an endogenous ligand for the pattern recognition receptor Dectin-1. , 2013, Cardiovascular research.

[13]  M. Karsdal,et al.  Circulating citrullinated vimentin fragments reflect disease burden in ankylosing spondylitis and have prognostic capacity for radiographic progression. , 2013, Arthritis and rheumatism.

[14]  Chiun Hsu,et al.  14-3-3ε Overexpression Contributes to Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma , 2013, PloS one.

[15]  G. Bhagat,et al.  Akt-Mediated Regulation of Autophagy and Tumorigenesis Through Beclin 1 Phosphorylation , 2012, Science.

[16]  J. Satsangi,et al.  A role for vimentin in Crohn disease , 2012, Autophagy.

[17]  U. Aebi,et al.  Atomic structure of the vimentin central α-helical domain and its implications for intermediate filament assembly , 2012, Proceedings of the National Academy of Sciences.

[18]  A. Valkna,et al.  Soluble CD44 Interacts with Intermediate Filament Protein Vimentin on Endothelial Cell Surface , 2011, PloS one.

[19]  A. Battler,et al.  Endothelial cell surface vimentin binding peptide induces angiogenesis under hypoxic/ischemic conditions. , 2011, Microvascular research.

[20]  Humberto E. Trejo,et al.  Vimentin is sufficient and required for wound repair and remodeling in alveolar epithelial cells , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  A. Satelli,et al.  Vimentin in cancer and its potential as a molecular target for cancer therapy , 2011, Cellular and Molecular Life Sciences.

[22]  U. Weidle,et al.  Intracellular proteins displayed on the surface of tumor cells as targets for therapeutic intervention with antibody-related agents. , 2011, Cancer genomics & proteomics.

[23]  Liming Wang,et al.  Sumoylation of Vimentin354 Is Associated with PIAS3 Inhibition of Glioma Cell Migration , 2010, Oncotarget.

[24]  R. Goldman,et al.  Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  D. Zacharias,et al.  Palmitoylation of cytoskeleton associated protein 4 by DHHC2 regulates antiproliferative factor-mediated signaling. , 2009, Molecular biology of the cell.

[26]  J. Clements,et al.  Epithelial—mesenchymal and mesenchymal—epithelial transitions in carcinoma progression , 2007, Journal of cellular physiology.

[27]  Johanna Ivaska,et al.  Novel functions of vimentin in cell adhesion, migration, and signaling. , 2007, Experimental cell research.

[28]  I. N. Reid,et al.  Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma , 2002, The Prostate.

[29]  K. Koda,et al.  The nature of an ideal therapeutic human antibody , 2002, Expert opinion on biological therapy.

[30]  K. Nagata,et al.  Protein kinases required for segregation of vimentin filaments in mitotic process , 2001, Oncogene.

[31]  M. Glassy,et al.  Immunoscreening protocols for the identification of clinically useful antibodies and antigens. , 1998, Expert opinion on investigational drugs.

[32]  M. Glassy,et al.  Pharming the human lymph node , 1994 .

[33]  T. Kokunai,et al.  Antigen related to cell proliferation in malignant gliomas recognized by a human monoclonal antibody. , 1990, Journal of neurosurgery.

[34]  Y. Aotsuka,et al.  Identification of a malignant cell associated antigen recognized by a human monoclonal antibody. , 1988, European journal of cancer & clinical oncology.

[35]  I. Royston,et al.  UC 729-6, a human lymphoblastoid B-cell line useful for generating antibody-secreting human-human hybridomas. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[36]  K. Weber,et al.  Identification and characterization of epithelial cells in mammalian tissues by immunofluorescence microscopy using antibodies to prekeratin. , 1979, Differentiation; research in biological diversity.

[37]  M. Glassy,et al.  Summary analysis of the pre-clinical and clinical results of brain tumor patients treated with pritumumab. , 2009, Human antibodies.

[38]  Jong-il Kim,et al.  HSP90 protects apoptotic cleavage of vimentin in geldanamycin-induced apoptosis , 2006, Molecular and Cellular Biochemistry.

[39]  D. Markovitz,et al.  Vimentin is secreted by activated macrophages , 2003, Nature Cell Biology.

[40]  T. Kokunai.  [Anti-TA226 human monoclonal antibody (ACA-11) against glioma]. , 2002, Nihon rinsho. Japanese journal of clinical medicine.

[41]  Y. Yamamoto,et al.  Determination of the antigen/epitope that is recognized by human monoclonal antibody CLN-IgG. , 2001, Human antibodies.

[42]  K Weber,et al.  Intermediate filaments: structure, dynamics, function, and disease. , 1994, Annual review of biochemistry.